Upper extremity deep vein thrombosis
- 865 Downloads
Upper extremities deep venous thrombosis (UEDVT) is a rare condition. According to the literature, approximately 4–10% of all cases of venous thrombosis may involve the subclavian, axillary or brachial veins. In the last few decades, the incidence of UEDVT has increased because of more frequent use of central venous catheters (CVCs) and cardiac pacemaker implantation. In addition, another common risk factor for UEDVT is cancer. UEDVT is classified as primary, approximately one-third of cases, which refers either to effort thrombosis or idiopathic UEDVT, or secondary, due to the presence of overt predisposing causes. The onset of UEDVT is usually characterized by arm swelling and pain, but may also be completely asymptomatic especially in patients with a long-term presence of a CVC. Ultrasonography represents a simple and accurate diagnostic tool to demonstrate the problem. UEDVT has major clinical consequences including pulmonary embolism, recurrences, post-thrombotic syndrome, and death. The role of thromboprophylaxis for those patients with a long-term CVC is still controversial. Unfractionated or low molecular weight heparin, followed by an oral anticoagulant are the most common treatments, with strategy of management similar to that of deep vein thrombosis of the leg. Thrombolysis/thrombectomy and surgical decompression are often successful, but less frequently used. Randomized controlled trials are warranted to clarify the optimal management of UEDVT, and to identify patients at the highest risk of recurrence who might benefit from long-term anticoagulation.
KeywordsUpper extremity deep vein thrombosis Central venous catheters Risk factors Prophylaxis and treatment of UEDVT
Conflict of interest statement
The authors declare that they have no conflict of interest related to the publication of this manuscript.
- 8.Von-Schroetter LF (1884) Erkrandungen der Gefaesse. In: Nothnagel H (ed) Spezielle Pathologie und Therapie. Nathnogel Handbuch der Pathologie und Therapie. Holder, ViennaGoogle Scholar
- 9.Paget J (1875) Clinical lectures and essays. Longmans Green, LondonGoogle Scholar
- 26.Sanders RJ, Haug CE (1991) Thoracic outlet syndrome: a common sequela of neck injuries. In: Lippincott WW (ed) Thoracic outlet syndrome. Lippincott, PhiladelphiaGoogle Scholar
- 31.Baarslag HJ, van Beek EJ, Koopman MMW, Reekers JA (2002) Prospective study of colour Duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 135:865–872Google Scholar
- 38.Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, Morrow B, Clement AM, Wells PS (2007) A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 5:1650–1653CrossRefPubMedGoogle Scholar
- 39.Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson D (2005) Randomised placebo-controlled study of low-dose warfarin for the prevention of central venous catheter related thrombosis in patients with cancer. J Clin Oncol 23:4063–4069CrossRefPubMedGoogle Scholar
- 40.Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, Shepherd S, Stanley A, Sweeney A, Wilde J, Wheatley K, on behalf of the WARP Collaborative Group, UK (2009) Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 373:567–574CrossRefPubMedGoogle Scholar
- 41.Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Sorarù M, Mosca S (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomised study in cancer patients. J Clin Oncol 23:4057–4062CrossRefPubMedGoogle Scholar
- 42.Abdelkefi A, Ben Othman T, Kammoun L, Chelli M, Romdhane NB, Kriaa A, Ladeb S, Torjman L, Lakhal A, Achour W, Ben Hassen A, Hsaïri M, Ladeb F, Ben Abdeladhim A (2004) Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomised controlled trial. Thromb Haemost 92:654–661PubMedGoogle Scholar